Red Light Therapy for Eye Floaters

Eye floaters — those drifting spots, threads, and cobweb-like shapes that move across your field of vision — affect the majority of adults by middle age. For most people, they are a mild annoyance. For a significant minority, floaters are severely disruptive, interfering with reading, driving, and quality of life.

The conventional medical response to floaters is typically reassurance: “you’ll get used to them.” When floaters are genuinely debilitating, the options are limited to vitrectomy (surgical removal of the vitreous gel) or YAG vitreolysis (laser treatment to break up floater strands). Both carry meaningful risks including retinal detachment, cataract formation, and incomplete resolution.

Red light therapy has been proposed as a non-invasive alternative. This page provides an honest assessment of what the evidence shows — and what it does not.

What causes eye floaters?

Understanding floaters requires understanding the vitreous body — the clear, gel-like substance that fills approximately 80 per cent of the eye’s volume. In youth, the vitreous is a homogeneous gel composed primarily of water, collagen (mostly type II), and hyaluronic acid.

As we age, the vitreous undergoes a process called syneresis — the collagen fibres aggregate and clump together whilst the hyaluronic acid degrades, creating pockets of liquid within the gel. These collagen aggregates cast shadows on the retina, which we perceive as floaters.

In many cases, the vitreous eventually separates from the retina entirely — a posterior vitreous detachment (PVD). This is extremely common after age 60 and often produces a sudden increase in floaters, sometimes accompanied by flashes of light. PVD itself is usually benign, but it can occasionally cause retinal tears or detachment.

Other causes of floaters include:

Inflammation — Uveitis or other inflammatory conditions can release cells and protein into the vitreous
Haemorrhage — Blood from damaged retinal vessels can enter the vitreous
Asteroid hyalosis — Calcium-lipid deposits suspended in the vitreous
Retinal tears — Can release pigment cells into the vitreous

The critical point for evaluating red light therapy is this: the most common floaters are structural — they consist of aggregated collagen fibres or condensed vitreous strands. Any therapy that claims to help must either dissolve these physical structures or alter how the eye processes them.

What the evidence says about red light therapy and floaters

To be direct: there are no published clinical trials examining red light therapy as a treatment for eye floaters. No randomised controlled trials, no case series in peer-reviewed journals, and no mechanistic studies specifically investigating whether photobiomodulation can influence vitreous collagen aggregation.

This does not mean the therapy is necessarily ineffective. It means we are working entirely from theoretical mechanisms and anecdotal reports. The distinction matters.

Theoretical mechanisms — what might help

Mitochondrial function in retinal cells. The retina is one of the most metabolically active tissues in the body. Photoreceptor cells contain dense concentrations of mitochondria, and cytochrome c oxidase — the primary chromophore for red and near-infrared light — is abundant. Begum et al. (2013) demonstrated that 670nm light improved mitochondrial function in ageing retinal cells in an animal model (Neurobiology of Aging, 34(3), 602-611).

However, improving retinal mitochondrial function addresses retinal health, not vitreous structure. Floaters are a vitreous problem, not a retinal problem.

Anti-inflammatory effects. If floaters are caused or worsened by intraocular inflammation, the anti-inflammatory properties of red light therapy could theoretically reduce inflammatory debris in the vitreous. Hamblin (2017) established that photobiomodulation reduces TNF-alpha, IL-1beta, and other pro-inflammatory cytokines (AIMS Biophysics, 4(3), 337-361).

This mechanism is only relevant for inflammatory floaters — not the vastly more common degenerative type caused by vitreous syneresis.

Neural adaptation. One of the ways people naturally adjust to floaters is through neuroadaptation — the brain learns to ignore stable visual disturbances. There is speculative interest in whether red light therapy might enhance neuroplasticity and accelerate this adaptation process. Rojas and Gonzalez-Lima (2011) demonstrated that transcranial photobiomodulation improved cognitive function, potentially through enhanced neuronal metabolism (Neuroscience, 205, 220-228). But this is a stretch — no research has connected photobiomodulation to visual neuroadaptation specifically.

What red light therapy cannot do for floaters

It cannot dissolve collagen aggregates. The collagen clumps that cause most floaters are structural proteins. Red and near-infrared light do not have the energy to break covalent bonds in collagen fibres. YAG laser vitreolysis works by delivering extremely high-energy, focused laser pulses that physically vaporise the collagen — a fundamentally different mechanism from low-level light therapy.

It cannot reverse vitreous liquefaction. Once the vitreous gel has undergone syneresis, the process is irreversible. No therapy — including red light therapy — can re-gel liquefied vitreous.

It cannot reattach the vitreous. Posterior vitreous detachment is a permanent structural change. The Weiss ring (the annular floater often seen after PVD) cannot be removed by light therapy.

Whilst the evidence for floaters specifically is absent, red light therapy has been studied for other ocular conditions:

Age-related macular degeneration (AMD). Markowitz et al. (2020) published a pilot study showing that photobiomodulation (670nm, 590nm, and 790nm) improved visual acuity in patients with dry AMD (Canadian Journal of Ophthalmology, 55(1), 21-27). The LIGHTSITE III trial further supported these findings.

Diabetic retinopathy. Animal studies have shown protective effects of 670nm light on retinal cells under metabolic stress, though human trials are limited.

Myopia control. Repeated low-level red light therapy (RLRL) has shown remarkable results in slowing myopia progression in children — see our myopia page for details.

These conditions involve retinal pathology, where photobiomodulation has a clear biological target. Floaters, by contrast, involve the vitreous — a largely acellular structure where the mechanisms of photobiomodulation have limited relevance.

Eye safety considerations

If you are considering any form of light therapy near the eyes, safety is paramount.

Red light (620 to 700nm) penetrates the eyelid and reaches the retina even with eyes closed. At therapeutic intensities used in red light therapy panels, this is generally considered safe for brief exposures — the retina is adapted to processing visible light. However, prolonged direct exposure at high irradiance could theoretically cause photothermal damage.

Near-infrared light (750 to 1000nm) is invisible and does not trigger the blink reflex. This makes it potentially more hazardous because you cannot tell when your exposure is excessive.

If you have any existing retinal condition — including retinal tears, macular degeneration, or diabetic retinopathy — do not use red light therapy near your eyes without consulting an ophthalmologist.

For any eye-area treatment, use a purpose-built device with appropriate intensity controls, and follow manufacturer guidelines precisely. Do not improvise with high-powered panels at close range.

The bottom line

Red light therapy is not a credible treatment for eye floaters based on current evidence. The fundamental problem — aggregated collagen and liquefied vitreous — is structural, and photobiomodulation does not have a mechanism to address structural protein changes in an acellular gel.

If your floaters are caused by or worsened by inflammation (as in uveitis), there is a theoretical basis for anti-inflammatory benefits, but this should be managed by an ophthalmologist rather than self-treated.

If your floaters are severely affecting your quality of life, the evidence-based options remain YAG vitreolysis for suitable cases and vitrectomy for severe cases. Discuss these with a vitreoretinal specialist.

Red light therapy has genuine and well-supported benefits for many conditions. Eye floaters, at present, is not one of them. If future research demonstrates otherwise, we will update this page accordingly.